環磷酰胺分析試劑盒-循環腫瘤細胞

CytoTrapNano®系統已用于同行評審的研究（見“應用”選項卡），以捕獲罕見的循環腫瘤細胞（CTC）。

用生物素化抗體標記的細胞被特異性地捕獲在CytoTrapNano®芯片上我們提供濃縮、固定和染色溶液來執行您的CTC分離分析。

點擊這里下載詳細的協議！

預期用途：僅供研究使用（RUO）。

關鍵技術特點：

技術平臺——CytoTrapNano®系統采用革命性的、細胞親和性納米結構基底分類平臺、集成微流控系統和新型免疫化學程序。

高特異性和準確度-證明了CytoTrapNano®系統捕獲CTC的能力，ICC和高分辨率形態學進一步證實了這一點。

經驗證的技術-多家醫療機構的科學驗證，結果發表在高影響力的同行評議期刊上。

利用CytoTrapNano®設備捕獲和鑒定CTC和其他稀有細胞

細胞捕捉和免疫熒光染色在Cytotrapnano®芯片上可以用熒光顯微鏡觀察。*Cytotrapnano®系統已用于臨床研究，以捕捉前列腺癌、皮膚癌、胰腺癌、肝癌、腎癌和肺癌患者的CTC。這些設備也被用于臨床研究，以捕獲和鑒定從孕婦血液中提取的稀有胎兒細胞這些結果發表在高影響力的期刊上。

*注：由于芯片的不透明性，顯微鏡的光源和透鏡必須在芯片的同一側。

對于涉及其他稀有細胞的研究，使用者需要使用自己的捕獲抗體和染色液。

環磷酰胺分析試劑盒-循環腫瘤細胞

The CytoTrapNano® system has been used in peer-reviewed studies (see them in the "Applications" tab) to capture rare circulating tumor cells (CTCs).

Cells tagged with biotinylated antibodies are specifically captured on the CytoTrapNano® chip. We provide enrichment, fixative and staining solutions to perform your assay of CTC isolation.

Click here to download the detailed protocol!

Intended Use: Research Use Only (RUO).

Key Technology Features:

• Patented Technology Platform - the CytoTrapNano® system employs a revolutionary, exclusively patented cell-affinity nanostructured substrate-based sorting platform, integrated microfluidic system, and novel immunochemistry procedure.

• High specificity and accuracy - Proven ability of the CytoTrapNano® system to capture CTCs, which is further confirmed with ICC and high-resolution morphology.

• Proven Technology - Scientific validation at multiple medical institutions, with results published in high-impact peer-reviewed journals.

Capture and Identification of CTCs and Other Rare Cells by CytoTrapNano® Devices

Cells captured and immuno-fluorescently stained on CytoTrapNano® Chips can be viewed with a fluorescent microscope.* The CytoTrapNano® System has been used in clinical research to capture CTCs from patients with prostate, skin, pancreatic, liver, kidney and lung cancers. These devices have also been used in clinical research to capture and identify rare fetal cells in blood drawn from pregnant mothers. These results were published in high-impact journals.

*Note:  Due to the opaque nature of the chips the microscope’s light source and lens must be on the same side of the chip.

For studies involving other rare cells, users will need to use their own capture antibodies and staining solutions.